Literature DB >> 8031792

The role of tyrosine 150 in catalysis of beta-lactam hydrolysis by AmpC beta-lactamase from Escherichia coli investigated by site-directed mutagenesis.

A Dubus1, S Normark, M Kania, M G Page.   

Abstract

The kinetics of beta-lactam hydrolysis by wild-type AmpC beta-lactamase from Escherichia coli and three mutant proteins created by substitution of tyrosine 150 have been examined. The catalytic efficiency was decreased 10- to 1000-fold according to the substrate and mutant being studied. The effect of the mutation was much stronger with rapidly hydrolyzed substrates (e.g., cephalothin) than it was with slowly hydrolyzed substrates (e.g., ceftriaxone). With the latter substrates, the mutagenesis had a much stronger effect on apparent affinity than it did on rates of catalysis. Indeed, the enzyme appeared to be more reactive toward certain of the slowly hydrolyzed substances (e.g., methicillin, aztreonam, and ceftriaxone). These observations were not compatible with an obligatory role of tyrosine 150 in catalysis. The analysis of the effects of the mutation on activity was complicated by the observation of at least two, kinetically distinct, forms of the enzymes. It appeared that mutation of tyrosine 150 influenced the kinetic properties of one state and that this residue is involved in the partitioning of the enzyme between the different reactive states.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8031792     DOI: 10.1021/bi00194a024

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  21 in total

Review 1.  Plasmid-determined AmpC-type beta-lactamases.

Authors:  Alain Philippon; Guillaume Arlet; George A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

2.  Structural study of phenyl boronic acid derivatives as AmpC beta-lactamase inhibitors.

Authors:  Donatella Tondi; Samuele Calò; Brian K Shoichet; Maria Paola Costi
Journal:  Bioorg Med Chem Lett       Date:  2010-04-09       Impact factor: 2.823

3.  Identification of residues critical for catalysis in a class C beta-lactamase by combinatorial scanning mutagenesis.

Authors:  Shalom D Goldberg; William Iannuccilli; Tuan Nguyen; Jingyue Ju; Virginia W Cornish
Journal:  Protein Sci       Date:  2003-08       Impact factor: 6.725

4.  AmpC and AmpH, proteins related to the class C beta-lactamases, bind penicillin and contribute to the normal morphology of Escherichia coli.

Authors:  T A Henderson; K D Young; S A Denome; P K Elf
Journal:  J Bacteriol       Date:  1997-10       Impact factor: 3.490

5.  The complexed structure and antimicrobial activity of a non-beta-lactam inhibitor of AmpC beta-lactamase.

Authors:  R A Powers; J Blázquez; G S Weston; M I Morosini; F Baquero; B K Shoichet
Journal:  Protein Sci       Date:  1999-11       Impact factor: 6.725

6.  Kinetic behavior of the major multidrug efflux pump AcrB of Escherichia coli.

Authors:  Keiji Nagano; Hiroshi Nikaido
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-23       Impact factor: 11.205

7.  Avibactam and class C β-lactamases: mechanism of inhibition, conservation of the binding pocket, and implications for resistance.

Authors:  S D Lahiri; M R Johnstone; P L Ross; R E McLaughlin; N B Olivier; R A Alm
Journal:  Antimicrob Agents Chemother       Date:  2014-07-14       Impact factor: 5.191

8.  Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii.

Authors:  M Afzal-Shah; N Woodford; D M Livermore
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

9.  A Unified Numbering Scheme for Class C β-Lactamases.

Authors:  Malcolm G P Page
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

10.  The deacylation mechanism of AmpC beta-lactamase at ultrahigh resolution.

Authors:  Yu Chen; George Minasov; Tomer A Roth; Fabio Prati; Brian K Shoichet
Journal:  J Am Chem Soc       Date:  2006-03-08       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.